Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rangering i aksjer #6083
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Aksjekurs
$153.90
Markedsverdi
$2.21B
Endring (1 dag)
-0.28%
Endring (1 år)
172.63%
Land
US
Handel Palvella Therapeutics, Inc. (PVLA)

Kategori

Historikk for aksjesplitt for Palvella Therapeutics, Inc. (PVLA)
Aksjen Palvella Therapeutics, Inc. (symbol: PVLA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 27, 2026.
Én PVLA-aksje kjøpt før Aug 27, 2026 tilsvarer i dag 0 PVLA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH